NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Vaccine Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Flu Vaccines



IDRI Makes Its Adjuvant Available to Increase Global Supply of Pandemic Vaccines



June 24th, 2009

Following the World Health Organization (WHO) declaration of swine flu pandemic, the Infectious Disease Research Institute (IDRI) announced it has successfully developed an adjuvant that could significantly enhance both the effectiveness and supplies of pandemic flu vaccines. The Seattle-based not-for-profit organization will make its adjuvant technology available to flu vaccine manufacturers for the production of A (H1N1) or future pandemic flu vaccines.

"As stressed by Dr. Chan at today's press conference, there is a real urgency to address the needs of developing countries for adequate supplies of swine flu pandemic vaccines. She rightly urged for global solidarity...


Source: Vaccine Weekly (2009-06-24)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login